Skip to main content
Fig. 1 | Malaria Journal

Fig. 1

From: ELQ-331 as a prototype for extremely durable chemoprotection against malaria

Fig. 1

Summary of Trial 1 protocol and results. The timepoints for blood stage challenges, blood sampling for snapshot pharmacokinetic analysis, and sporozoite challenges are noted on the x-axis. The outcomes of efficacy trials are represented graphically as red = no protection and green = complete protection, and the proportion of challenged mice with each outcome is noted. The table insert summarizes the results of snapshot PK at the indicated timepoints

Back to article page